{"id":7348,"date":"2023-10-16T15:35:49","date_gmt":"2023-10-16T07:35:49","guid":{"rendered":"https:\/\/www.eisai.com.cn\/?p=7348"},"modified":"2023-10-16T15:49:13","modified_gmt":"2023-10-16T07:49:13","slug":"7348","status":"publish","type":"post","link":"https:\/\/www.eisai.com.cn\/2023\/10\/16\/7348\/","title":{"rendered":"\u536b\u6750\u5c06\u5728\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u4e34\u5e8a\u8bd5\u9a8c\uff08CTAD\uff09\u4f1a\u8bae\u4e0a\u5c55\u793aLeqembi\u00ae (lecanemab-irmb) III \u671f\u4e34\u5e8a\u7814\u7a76\u7684\u6700\u65b0\u6570\u636e\u53ca\u5176\u5b83\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u7ba1\u7ebf\u7814\u7a76\u6210\u679c"},"content":{"rendered":"

LEQEMBI \u76ae\u4e0b\u6ce8\u5c04\u5242\u578b\u7684\u6700\u65b0\u7814\u7a76\u8fdb\u5c55<\/h2>\n
<\/p>\n
\u536b\u6750\u682a\u5f0f\u4f1a\u793e\u5ba3\u5e03\uff0c\u5c06\u5728\u7b2c16\u5c4a\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u4e34\u5e8a\u8bd5\u9a8c\uff08CTAD\uff09\u5e74\u4f1a\u4e0a\u516c\u5e03\u5176\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\uff08AD\uff09\u6cbb\u7597\u836f\u7269LEQEMBI\u00ae\uff08lecanemab-irmb\uff09100 mg\/mL\u7684III\u671fClarity AD\u7814\u7a76\u7684\u6700\u65b0\u6570\u636e\u4ee5\u53ca\u6b63\u5728\u5f00\u53d1\u7684\u76ae\u4e0b\u5236\u5242\u7684\u65b0\u6570\u636e\uff0c\u8be5\u4f1a\u8bae\u5c06\u4e8e2023\u5e7410\u670824\u65e5\u81f327\u65e5\u5728\u7f8e\u56fd\u9a6c\u8428\u8bf8\u585e\u5dde\u6ce2\u58eb\u987f\u4e3e\u884c\u3002\u4f1a\u8bae\u4e0a\uff0c\u9664\u4e86\u4ecb\u7ecd\u536b\u6750LEQEMBI\u7684\u6570\u636e\u5916\uff0c\u8fd8\u5c06\u4ecb\u7ecdE2511\uff08\u4e00\u79cd\u7814\u7a76\u6027\u539f\u808c\u7403\u86cb\u767d\u53d7\u4f53\u6fc0\u9176A\uff08TrkA\uff09\u9633\u6027\u53d8\u6784\u8c03\u8282\u5242\uff08PAM\uff09\uff09\u7684I\u671f\u6570\u636e\u4ee5\u53ca\u516c\u53f8AD\u4ea7\u54c1\u7ebf\u7684\u5176\u5b83\u7814\u7a76\u3002\u5728\u6b64\u6b21\u4f1a\u8bae\u4e0a\uff0c\u536b\u6750\u5c06\u901a\u8fc7\u4e94\u573a\u53e3\u5934\u62a5\u544a\u548c\u5341\u573a\u6d77\u62a5\u5c55\u793a\u6765\u4ecb\u7ecd\u6570\u636e\u548c\u7814\u7a76\u6210\u679c\u3002BioArctic \u5c06\u5c31 lecanemab \u4f5c\u53e3\u5934\u62a5\u544a\u3002<\/p>\n
\u6700\u65b0\u4e13\u9898\u7814\u8ba8\u4f1a4\u2014\u2014Lecanemab\u6cbb\u7597\u65e9\u671f\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\uff1a\u957f\u671f\u7597\u6548\u3001\u9884\u6d4b\u6027\u751f\u7269\u6807\u5fd7\u7269\u548c\u65b0\u578b\u76ae\u4e0b\u7ed9\u836f<\/p>\n
\n
\u5728\u7f8e\u56fd\u4e1c\u90e8\u65f6\u95f410\u670825\u65e517:25-18:05\u4e3e\u884c\u7684\u4e00\u6b21\u7a81\u7834\u6027\u7814\u8ba8\u4f1a\u4e0a\uff0c\u536b\u6750\u5c06\u5c55\u793aClarity AD\u53ef\u9009tau PET\u7eb5\u5411\u5b50\u7814\u7a76\u7684\u6700\u65b0\u6570\u636e\u3002\u8be5\u6f14\u793a\u5c06\u5305\u62ec\u5bf9\u4f4e\u548c\u4e2d\u7b49+\u9ad8tau\u4e9a\u7ec4\u7684\u4e8b\u540e\u5206\u6790\uff0c\u4f4etau\u4e9a\u7ec4\u4ee3\u8868\u75be\u75c5\u7684\u65e9\u671f\u9636\u6bb5\uff0c\u7279\u522b\u662f\u5728III\u671f\u6838\u5fc3\u7814\u7a76\u548c\u5f00\u653e\u6807\u7b7e\u6269\u5c55\u7814\u7a76\u4e2d\u8fdb\u884c\u7814\u7a76\u3002\u6b64\u5916\uff0c\u8fd8\u5c06\u4ecb\u7ecd\u7814\u7a76\u76ae\u4e0b\u5236\u5242\u7684\u6700\u65b0\u60c5\u51b5\uff0c\u5305\u62ec\u4e2d\u671f\u5b89\u5168\u6027\u548c\u6dc0\u7c89\u6837\u86cb\u767d PET \u5bf9\u5927\u8111\u4e2d\u6dc0\u7c89\u6837\u86cb\u767d\u7684\u5f71\u54cd\u3002<\/li>\n
Christopher van Dyck\u533b\u5b66\u535a\u58eb\u3001Keith Johnson\u533b\u5b66\u535a\u58eb\u548cReisa Sperling\u533b\u5b66\u535a\u58eb\u5c06\u5728\u536b\u6750Michael Irizarry\u533b\u5b66\u535a\u58eb\uff08\u516c\u5171\u536b\u751f\u7855\u58eb\uff09\u4e3b\u6301\u7684\u5c0f\u7ec4\u8ba8\u8bba\u4e2d\u8ba8\u8bba\u8fd9\u4e9b\u53d1\u73b0\u3002<\/li>\n
\u672c\u6b21\u7814\u8ba8\u4f1a\u7684\u7f51\u7edc\u76f4\u64ad\u53ef\u5728\u536b\u6750\u682a\u5f0f\u4f1a\u793e\u7f51\u7ad9\u4e0a\u89c2\u770b\u3002<\/li>\n<\/ul>\n
\u536b\u6750\u795e\u7ecf\u5185\u79d1\u4e34\u5e8a\u7814\u7a76\u9ad8\u7ea7\u526f\u603b\u88c1\u3001\u4e34\u5e8a\u8bc1\u636e\u751f\u6210\u90e8\u526f\u9996\u5e2d\u4e34\u5e8a\u5b98Michael Irizarry\u533b\u5b66\u535a\u58eb\u8868\u793a\uff0c”\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u662f\u4e00\u79cd\u6e10\u8fdb\u6027\u7684\u987d\u56fa\u75be\u75c5\uff0c\u9700\u8981\u65e9\u671f\u8bca\u65ad\u548c\u6301\u7eed\u6cbb\u7597\u3002LEQEMBI\u80fd\u591f\u6e05\u9664\u9ad8\u6bd2\u6027\u539f\u7ea4\u7ef4\uff0c\u4ece\u800c\u652f\u6301\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u7684\u795e\u7ecf\u5143\u529f\u80fd\uff0c\u800c\u9ad8\u6bd2\u6027\u539f\u7ea4\u7ef4\u5728\u6591\u5757\u88ab\u6e05\u9664\u540e\u4ecd\u4f1a\u7ee7\u7eed\u5bfc\u81f4\u795e\u7ecf\u5143\u635f\u4f24\u548c\u6b7b\u4ea1\u3002\u6211\u4eec\u671f\u5f85\u57282023\u5e74CTAD\u4e0a\u5206\u4eab\u65b0\u7684LEQEMBI\u4f4etau\u4e9a\u7ec4\u6570\u636e\u548c\u76ae\u4e0b\u6ce8\u5c04\u6570\u636e\u3002”<\/p>\n
\u5176\u5b83\u4e3b\u8981\u53e3\u5934\u62a5\u544a\u5305\u62ec<\/p>\n
\n
Lecanemab\uff1alecanemab\u548cdonanemab\u4e0e\u4e0d\u540c\u6dc0\u7c89\u6837\u86cb\u767d-\u03b2\u7684\u7ed3\u5408\u6982\u51b5\uff08OC19\uff0c\u7531BioArctic\u516c\u53f8\u4ecb\u7ecd\uff09\u3002<\/li>\n
\u65b0\u578bTrkA\u8c03\u8282\u5242E2511\u5728 I\u671f\u4e34\u5e8a\u7814\u7a76\u4e2d\u4e0e\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u80c6\u78b1\u80fd\u9776\u70b9\u7ed3\u5408\uff08OC34\uff09\u3002<\/li>\n
\u65b0\u578bCSF tau\u751f\u7269\u6807\u5fd7\u7269\u53ef\u7528\u4e8e\u6563\u53d1\u6027\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u7684\u75be\u75c5\u5206\u671f\uff08OC2\uff09\u3002<\/li>\n<\/ul>\n
\u536b\u6750\u6f14\u8bb2\u5217\u8868\u5982\u4e0b:<\/p>\n
$\"\"$ <\/p>\n
\u672c\u65b0\u95fb\u7a3f\u8ba8\u8bba\u4e86\u836f\u7269\u5728\u5f00\u53d1\u4e2d\u7814\u7a76\u6027\u7528\u9014\uff0c\u5e76\u975e\u4f20\u8fbe\u5173\u4e8e\u7597\u6548\u548c\u5b89\u5168\u6027\u7684\u7ed3\u8bba\uff0c\u4e0d\u4fdd\u8bc1\u4efb\u4f55\u7814\u7a76\u6027\u836f\u7269\u5c06\u6210\u529f\u5b8c\u6210\u4e34\u5e8a\u5f00\u53d1\u6216\u83b7\u5f97\u836f\u54c1\u76d1\u7ba1\u673a\u6784\u6279\u51c6\u3002<\/p>\n
<\/p>\n
MEDIA CONTACTS:
\nEisai Co., Ltd.
\nPublic Relations Department
\nTEL: +81 (0)3-3817-5120<\/p>\n
Eisai Inc. (U.S.)
\nLibby Holman
\n+ 1-201-753-1945
\nLibby_Holman@Eisai.com<\/p>\n
Eisai Europe, Ltd.
\n(UK, Europe, Australia, New Zealand and Russia)
\nEMEA Communications Department
\n+44 (0) 786 601 1272
\nEMEA-comms@eisai.net<\/p>\n","protected":false},"excerpt":{"rendered":"
LEQEMBI \u76ae\u4e0b\u6ce8\u5c04\u5242\u578b\u7684\u6700\u65b0\u7814\u7a76\u8fdb\u5c55<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-7348","post","type-post","status-publish","format-standard","hentry","category-news-zh"],"_links":{"self":[{"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/posts\/7348"}],"collection":[{"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/comments?post=7348"}],"version-history":[{"count":7,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/posts\/7348\/revisions"}],"predecessor-version":[{"id":7356,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/posts\/7348\/revisions\/7356"}],"wp:attachment":[{"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/media?parent=7348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/categories?post=7348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eisai.com.cn\/wp-json\/wp\/v2\/tags?post=7348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}